Trade Summary

3 days ago, Brady Todd C, serving as President and CEO at Aldeyra Therapeutics, Inc. (ALDX), purchased 250,000 shares at $1.67 per share, for a total transaction value of $418,450.00. Following this transaction, Brady Todd C now holds 1,721,298 shares of ALDX.

This purchase represents a 16.99% increase in Brady Todd C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, June 3, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 4:19 PM ET, 2 days after the trade was made.

Aldeyra Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.